Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Publication year range
1.
Lupus ; 32(2): 180-188, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36444940

ABSTRACT

OBJECTIVE: To study ophthalmological manifestations in a well-characterized primary antiphospholipid syndrome (PAPS) cohort (APS-Rio) and compare them with a healthy control group. METHODS: We examined PAPS patients and controls with an extensive ophthalmological evaluation, which included anamnesis, visual acuity, slit-lamp biomicroscopy, binocular indirect ophthalmoscopy, and retinography of the anterior and posterior segments of the eye. PAPS group also underwent angiography exam and optical coherence tomography using spectral domain technology (SD-OCT). RESULTS: 98 PAPS patients and 102 controls were included. The most common symptom in PAPS was amaurosis fugax (34.7% vs. 6.9%; p = .001). In the multivariate analyses, Raynaud's phenomenon was associated with amaurosis fugax (OR 3.71, CI:1.33-10.32; p = .012), and livedo correlated with hemianopia (OR 6.96, CI:1.11-43.72, p = .038) and diplopia (OR 3.49, CI:1.02-11.53, p = .047). After ophthalmological evaluation, 84 PAPS patients had ocular involvement (1.0% glaucoma, 94.0% posterior findings, 62.7% anterior findings, and 56.6% both posterior and anterior findings). Vascular tortuosity was more frequent in the PAPS group (63.2% vs. 42.2%; p = .002), as well as peripheral tortuosity (29.6% vs. 7.8%; p < .001). After excluding patients with atherosclerotic risk factors, peripheral vascular tortuosity was still statistically associated with PAPS (35.0 vs. 7.8%, p < .001). Triple positivity was more frequent in PAPS patients with peripheral vascular tortuosity than in those without this ocular finding (34.5% vs. 15.9%, p = .041). CONCLUSION: Vasomotor phenomena are importantly related to ocular symptoms in PAPS. Vascular tortuosity was a frequent finding in PAPS patients. Peripheral vascular tortuosity was associated with triple positivity and might be a biomarker of ischemic microvascular retinopathy due to PAPS.


Subject(s)
Antiphospholipid Syndrome , Lupus Erythematosus, Systemic , Retinal Diseases , Humans , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Amaurosis Fugax/complications , Lupus Erythematosus, Systemic/complications , Arteries
2.
Pathol Res Pract ; 210(11): 739-45, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25041838

ABSTRACT

INTRODUCTION: Focal adhesion kinase (FAK) is implicated in tumor progression and metastatic cascade, and has been shown to be overexpressed in a variety of human cancers. However, the role of FAK in human uveal melanoma (UM) is not well defined. The purpose of this study was to evaluate the expression of FAK in UM tumors and normal eyes, and to determine the effect of Hsp90 inhibition on FAK expression in UM cells. METHODS: FAK expression was assessed in 39 UM specimens, FAK[pY397] expression was assessed in 51 UM specimens, and both FAK and FAK[pY397] expression were assessed in 20 normal eyes. The expression of FAK and FAK[pY397] was detected by Western blot in five UM cell lines after treatment with 10 µmol/L of 17-AAG. RESULTS: FAK was positive in 87.2% and FAK[pY397] in 90% of UM specimens. Low FAK expression was detected in non-tumor structures and in normal eyes. The cell lines with the most proliferative, invasive phenotype (92.1, SP6.5 and MKT-BR) displayed high expression of FAK[pY397], and the levels of FAK and FAK[pY397] were decreased in the presence of 17-AAG starting with 24 h of exposure. CONCLUSION: FAK and FAK[pY397] were overexpressed in human UM tumors compared to normal ocular tissue and high levels of FAK[pY397] were seen in the most aggressive UM cell lines. Hsp90 inhibition led to downregulation of FAK expression. We propose a role for FAK in the pathogenesis of UM. Future studies are needed to explore the use of Hsp90 inhibitors as a feasible approach for modulating FAK in UM.


Subject(s)
Benzoquinones/pharmacology , Focal Adhesion Kinase 1/metabolism , Gene Expression Regulation, Neoplastic , HSP90 Heat-Shock Proteins/antagonists & inhibitors , Lactams, Macrocyclic/pharmacology , Melanoma/metabolism , Uveal Neoplasms/metabolism , Cell Line, Tumor , Down-Regulation , HSP90 Heat-Shock Proteins/metabolism , Humans , Immunohistochemistry , Melanoma/pathology , Uveal Neoplasms/pathology
3.
GED gastroenterol. endosc. dig ; 25(6): 175-179, nov.-dez. 2006. ilus, tab
Article in Portuguese | LILACS | ID: lil-544038

ABSTRACT

Os tumores neuroendócrinos do duodeno compreendem 2-3 por cento de todos os tumores endócrinos do trato gastrointestinal, sendo o gastrinoma o mais freqüente, representando aproximadamente 48 por cento dos casos. Essas lesões, em 90 por cento dos ca»os, estão localizadas no triângulo do gastrinoma, que compreende, entre outras regiões, a primeira, segunda e terceira porção duodenal. Cerca de 25 por cento dessas lesões estão associadas à neoplasia endócrina múltipla tipo 1 (NEM-l). O presente relato demonstra paciente com familiares de primeiro grau portadores da síndrome e que estava em programa de rastreamento para pesquisa de NEM-l familiar. Durante a realização de ultra-som endoscópico, evidenciou-se lesão em região parapapilar com origem na camada mucosa de parede duodenal. Foram realizadas pun-ções-biópsias ecoguiadas e a análise histopatológica e imunohistoquímica revelou tratar-se de neoplasia endócrina produtora de gastrina. O estudo relatado evidencia um raro caso de gas-trinoma de região parapapilar em indivíduo portador de NEM-l.


Subject(s)
Humans , Male , Adult , Gastrinoma , Multiple Endocrine Neoplasia Type 1 , Neuroendocrine Tumors , Biopsy, Needle , Clinical Laboratory Techniques , Diagnostic Imaging , Endosonography , Gastritis , Genetic Determinism , Omeprazole , Peptic Ulcer
SELECTION OF CITATIONS
SEARCH DETAIL